Profound Medical Corp
TSX:PRN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ANTA Sports Products Ltd
OTC:ANPDY
|
CN |
|
C
|
China Fordoo Holdings Ltd
HKEX:2399
|
CN |
|
REV Group Inc
NYSE:REVG
|
US |
|
QXO Inc
NYSE:QXO
|
US |
|
Toyo Wharf & Warehouse Co Ltd
TSE:9351
|
JP |
|
H
|
Hengbao Co Ltd
SZSE:002104
|
CN |
|
Thunder Software Technology Co Ltd
SZSE:300496
|
CN |
|
P
|
Pulike Biological Engineering Inc
SSE:603566
|
CN |
|
B
|
Bajaj Steel Industries Ltd
BSE:507944
|
IN |
|
O
|
OpenWork Inc
TSE:5139
|
JP |
Profound Medical Corp
Stock-Based Compensation
Profound Medical Corp
Stock-Based Compensation Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Stock-Based Compensation | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Profound Medical Corp
TSX:PRN
|
Stock-Based Compensation
$5.5m
|
CAGR 3-Years
9%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
Theralase Technologies Inc
XTSX:TLT
|
Stock-Based Compensation
CA$697.7k
|
CAGR 3-Years
62%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
MedMira Inc
XTSX:MIR
|
Stock-Based Compensation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Aurora Spine Corp
XTSX:ASG
|
Stock-Based Compensation
$87.7k
|
CAGR 3-Years
-15%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-7%
|
|
|
O
|
Ondine Biomedical Inc
LSE:OBI
|
Stock-Based Compensation
CA$895k
|
CAGR 3-Years
-39%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Conavi Medical Corp
XTSX:CNVI
|
Stock-Based Compensation
$672k
|
CAGR 3-Years
-50%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
2%
|
|
Profound Medical Corp
Glance View
Profound Medical Corp. develops, manufactures and markets therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. The company is headquartered in Mississauga, Ontario and currently employs 146 full-time employees. The company went IPO on 2014-09-24. The firm is commercializing TULSA-PRO, which is a technology that combines real-time magnetic resonance imaging (MRI), transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO is designed to provide customizable and predictable radiation-free ablation of a surgeon-defined prostate volume while protecting the urethra and rectum to help preserve the patient’s natural functional abilities. The firm is also commercializing Sonalleve, which is a therapeutic platform for the treatment of uterine fibroids and palliative pain treatment of bone metastases.
See Also
What is Profound Medical Corp's Stock-Based Compensation?
Stock-Based Compensation
5.5m
USD
Based on the financial report for Dec 31, 2025, Profound Medical Corp's Stock-Based Compensation amounts to 5.5m USD.
What is Profound Medical Corp's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 5Y
13%
Over the last year, the Stock-Based Compensation growth was 113%. The average annual Stock-Based Compensation growth rates for Profound Medical Corp have been 9% over the past three years , 13% over the past five years .
